Reschke lab
@drrobinreschke.bsky.social
Max-Eder Research Group Leader & Physician Scientist @NCT @DKFZ @DKTK @Uniklinik_HD
TRYTRAC @CancerCoreEurope
before PostDoc @Uchicago Gajewski lab
#skin #cancer #immunology #spatialbiology #dermatology
TRYTRAC @CancerCoreEurope
before PostDoc @Uchicago Gajewski lab
#skin #cancer #immunology #spatialbiology #dermatology
Pinned
Reschke lab
@drrobinreschke.bsky.social
· Dec 28
Hot off the press 🔥
Very proud of this collaboration! 💫
@Harvard
@JohnsHopkins
@UChicago
@UniHeidelberg
Interested in immunotherapy-induced toxicity? 🤓
This is a must-read 🤩
#immunology #science #cancer #research
@nct-heidelberg.bsky.social @dkfz.bsky.social
www.cell.com/trends/immun...
Very proud of this collaboration! 💫
@Harvard
@JohnsHopkins
@UChicago
@UniHeidelberg
Interested in immunotherapy-induced toxicity? 🤓
This is a must-read 🤩
#immunology #science #cancer #research
@nct-heidelberg.bsky.social @dkfz.bsky.social
www.cell.com/trends/immun...
✨ Grateful for the opportunity to present some data from my lab today at #EACR2025 in Lisbon! 🧬🔬🇵🇹
It was a pleasure to engage with such an inspiring community of researchers.💡🙌 Thanks to everyone who stopped by, asked questions, and shared ideas — exciting things ahead! 🚀
@helloeacr.bsky.social
It was a pleasure to engage with such an inspiring community of researchers.💡🙌 Thanks to everyone who stopped by, asked questions, and shared ideas — exciting things ahead! 🚀
@helloeacr.bsky.social
June 16, 2025 at 3:43 PM
✨ Grateful for the opportunity to present some data from my lab today at #EACR2025 in Lisbon! 🧬🔬🇵🇹
It was a pleasure to engage with such an inspiring community of researchers.💡🙌 Thanks to everyone who stopped by, asked questions, and shared ideas — exciting things ahead! 🚀
@helloeacr.bsky.social
It was a pleasure to engage with such an inspiring community of researchers.💡🙌 Thanks to everyone who stopped by, asked questions, and shared ideas — exciting things ahead! 🚀
@helloeacr.bsky.social
First time at #EACR — excited to kick off this incredible meeting in beautiful Lisbon! Let the science (and sunshine) begin ☀️🇵🇹
@EACRnews #Lisboa #EACR2025 @helloeacr.bsky.social
@EACRnews #Lisboa #EACR2025 @helloeacr.bsky.social
June 15, 2025 at 12:47 PM
First time at #EACR — excited to kick off this incredible meeting in beautiful Lisbon! Let the science (and sunshine) begin ☀️🇵🇹
@EACRnews #Lisboa #EACR2025 @helloeacr.bsky.social
@EACRnews #Lisboa #EACR2025 @helloeacr.bsky.social
Feeling very grateful! 🤩🎉
A heartfelt thank you to my amazing MD students for the kind congratulations on my successful habilitation as Privatdozent (Priv.-Doz.) 🐥🎓 😁
A heartfelt thank you to my amazing MD students for the kind congratulations on my successful habilitation as Privatdozent (Priv.-Doz.) 🐥🎓 😁
June 12, 2025 at 11:08 AM
Feeling very grateful! 🤩🎉
A heartfelt thank you to my amazing MD students for the kind congratulations on my successful habilitation as Privatdozent (Priv.-Doz.) 🐥🎓 😁
A heartfelt thank you to my amazing MD students for the kind congratulations on my successful habilitation as Privatdozent (Priv.-Doz.) 🐥🎓 😁
Stellar Keynote lecture from Laura Mackay on TRM cell fate at #SID25 in San Diego @siderm.bsky.social 🤓🤩🎉
May 10, 2025 at 3:39 PM
Stellar Keynote lecture from Laura Mackay on TRM cell fate at #SID25 in San Diego @siderm.bsky.social 🤓🤩🎉
Big thanks to the Society for Investigative Dermatology for an amazing meeting in San Diego so far! Honored to receive an award for our work and the invitation to present 🥳Grateful for the inspiring science, conversations, and community! ☀️#SID2025#DermResearch
@siderm.bsky.social
@siderm.bsky.social
May 9, 2025 at 5:31 AM
Big thanks to the Society for Investigative Dermatology for an amazing meeting in San Diego so far! Honored to receive an award for our work and the invitation to present 🥳Grateful for the inspiring science, conversations, and community! ☀️#SID2025#DermResearch
@siderm.bsky.social
@siderm.bsky.social
Reposted by Reschke lab
Auftakt für TRYTRAC, das europäische Nachwuchsprogramm von Cancer Core Europe (CCE): Junge Wissenschaftler:innen aus sieben Top-Krebszentren – darunter vier Fellows aus Heidelberg – trafen sich am Karolinska Institutet in Stockholm.
🔗 www.nct-heidelberg.de/das-nct/news...
🔗 www.nct-heidelberg.de/das-nct/news...
April 15, 2025 at 1:31 PM
Auftakt für TRYTRAC, das europäische Nachwuchsprogramm von Cancer Core Europe (CCE): Junge Wissenschaftler:innen aus sieben Top-Krebszentren – darunter vier Fellows aus Heidelberg – trafen sich am Karolinska Institutet in Stockholm.
🔗 www.nct-heidelberg.de/das-nct/news...
🔗 www.nct-heidelberg.de/das-nct/news...
Reposted by Reschke lab
Recommended 📖 “Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicities” @natureportfolio.nature.com co-authored by @drrobinreschke.bsky.social from @nct-heidelberg.bsky.social @dkfz.bsky.social
🔗 www.nature.com/articles/s41...
🔗 www.nature.com/articles/s41...
Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicities - Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy - Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicities
https://www.nature.com/articles/s41392-025-02205-y\
April 16, 2025 at 7:29 AM
Recommended 📖 “Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicities” @natureportfolio.nature.com co-authored by @drrobinreschke.bsky.social from @nct-heidelberg.bsky.social @dkfz.bsky.social
🔗 www.nature.com/articles/s41...
🔗 www.nature.com/articles/s41...
Reposted by Reschke lab
🚨New research highlight: study on managing immunotherapy side effects without weakening anti-tumor power!
ECP reduces harmful immune activity via neutrophils/T cells & promotes M2 macrophages via adiponectin.
Promising results from Zeiser et al. 🔬 🧪 🧫
Full summary:
www.nature.com/articles/s41...
ECP reduces harmful immune activity via neutrophils/T cells & promotes M2 macrophages via adiponectin.
Promising results from Zeiser et al. 🔬 🧪 🧫
Full summary:
www.nature.com/articles/s41...
Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicities - Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy - Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicities
www.nature.com
April 11, 2025 at 9:20 AM
🚨New research highlight: study on managing immunotherapy side effects without weakening anti-tumor power!
ECP reduces harmful immune activity via neutrophils/T cells & promotes M2 macrophages via adiponectin.
Promising results from Zeiser et al. 🔬 🧪 🧫
Full summary:
www.nature.com/articles/s41...
ECP reduces harmful immune activity via neutrophils/T cells & promotes M2 macrophages via adiponectin.
Promising results from Zeiser et al. 🔬 🧪 🧫
Full summary:
www.nature.com/articles/s41...
Reposted by Reschke lab
📖 “Targeting molecular pathways to control immune checkpoint inhibitor toxicities” co-authored by @drrobinreschke.bsky.social from @nct-heidelberg.bsky.social @dkfz.bsky.social
🔗 https://www.cell.com/trends/immunology/fulltext/S1471-4906(24)00299-0
🔗 https://www.cell.com/trends/immunology/fulltext/S1471-4906(24)00299-0
January 28, 2025 at 10:02 AM
📖 “Targeting molecular pathways to control immune checkpoint inhibitor toxicities” co-authored by @drrobinreschke.bsky.social from @nct-heidelberg.bsky.social @dkfz.bsky.social
🔗 https://www.cell.com/trends/immunology/fulltext/S1471-4906(24)00299-0
🔗 https://www.cell.com/trends/immunology/fulltext/S1471-4906(24)00299-0
Reposted by Reschke lab
Heidelberg is placing first when it comes to #startup founders per capita in #Germany. With 13.5 new startups per 100.000 inhabitants in 2024, Heidelberg is outperforming startup hotspots such as #Berlin and #Munich.
The full report is here:
startupverband.de/fileadmin/st...
The full report is here:
startupverband.de/fileadmin/st...
January 15, 2025 at 12:45 PM
Heidelberg is placing first when it comes to #startup founders per capita in #Germany. With 13.5 new startups per 100.000 inhabitants in 2024, Heidelberg is outperforming startup hotspots such as #Berlin and #Munich.
The full report is here:
startupverband.de/fileadmin/st...
The full report is here:
startupverband.de/fileadmin/st...
Now featured and OPEN ACCESS 💫👏🏻🚀
Review: Targeting molecular pathways to control immune checkpoint inhibitor toxicities
www.cell.com/trends/immun...
www.cell.com/trends/immun...
January 15, 2025 at 5:11 PM
Now featured and OPEN ACCESS 💫👏🏻🚀
Reposted by Reschke lab
Targeting molecular pathways to control immune checkpoint inhibitor toxicities
@drrobinreschke.bsky.social
@jhu.edu @harvard.edu
oncodaily.com/science/immu...
#Cancer #CancerTreatment #ImmuneCheckpointBlockade #OncoDaily #Oncology #Medicine #Health
@drrobinreschke.bsky.social
@jhu.edu @harvard.edu
oncodaily.com/science/immu...
#Cancer #CancerTreatment #ImmuneCheckpointBlockade #OncoDaily #Oncology #Medicine #Health
Targeting molecular pathways to control immune checkpoint inhibitor toxicities - OncoDaily
Targeting molecular pathways to control immune checkpoint inhibitor toxicities / Alexander H. Enk, cancer, cancer treatment, Evan J Lipson, Harvard
oncodaily.com
December 30, 2024 at 1:05 PM
Targeting molecular pathways to control immune checkpoint inhibitor toxicities
@drrobinreschke.bsky.social
@jhu.edu @harvard.edu
oncodaily.com/science/immu...
#Cancer #CancerTreatment #ImmuneCheckpointBlockade #OncoDaily #Oncology #Medicine #Health
@drrobinreschke.bsky.social
@jhu.edu @harvard.edu
oncodaily.com/science/immu...
#Cancer #CancerTreatment #ImmuneCheckpointBlockade #OncoDaily #Oncology #Medicine #Health
Reposted by Reschke lab
Comprehensive interdisciplinary review on current and emerging therapeutic targets to treat immune-related adverse events (irAE). A rapidly evolving field of high clinical relevance elegantly summarized by Jessica Hassel and colleagues @dkfz.bsky.social @cellpress.bsky.social doi.org/10.1016/j.it...
December 30, 2024 at 8:08 AM
Comprehensive interdisciplinary review on current and emerging therapeutic targets to treat immune-related adverse events (irAE). A rapidly evolving field of high clinical relevance elegantly summarized by Jessica Hassel and colleagues @dkfz.bsky.social @cellpress.bsky.social doi.org/10.1016/j.it...
Reposted by Reschke lab
Review: Targeting molecular pathways to control immune checkpoint inhibitor toxicities
www.cell.com/trends/immun...
www.cell.com/trends/immun...
December 29, 2024 at 10:19 PM
Review: Targeting molecular pathways to control immune checkpoint inhibitor toxicities
www.cell.com/trends/immun...
www.cell.com/trends/immun...
Hot off the press 🔥
Very proud of this collaboration! 💫
@Harvard
@JohnsHopkins
@UChicago
@UniHeidelberg
Interested in immunotherapy-induced toxicity? 🤓
This is a must-read 🤩
#immunology #science #cancer #research
@nct-heidelberg.bsky.social @dkfz.bsky.social
www.cell.com/trends/immun...
Very proud of this collaboration! 💫
@Harvard
@JohnsHopkins
@UChicago
@UniHeidelberg
Interested in immunotherapy-induced toxicity? 🤓
This is a must-read 🤩
#immunology #science #cancer #research
@nct-heidelberg.bsky.social @dkfz.bsky.social
www.cell.com/trends/immun...
December 28, 2024 at 8:02 AM
Hot off the press 🔥
Very proud of this collaboration! 💫
@Harvard
@JohnsHopkins
@UChicago
@UniHeidelberg
Interested in immunotherapy-induced toxicity? 🤓
This is a must-read 🤩
#immunology #science #cancer #research
@nct-heidelberg.bsky.social @dkfz.bsky.social
www.cell.com/trends/immun...
Very proud of this collaboration! 💫
@Harvard
@JohnsHopkins
@UChicago
@UniHeidelberg
Interested in immunotherapy-induced toxicity? 🤓
This is a must-read 🤩
#immunology #science #cancer #research
@nct-heidelberg.bsky.social @dkfz.bsky.social
www.cell.com/trends/immun...
⚠️ Anti-PD1 therapy could serve as an effective systemic treatment for patients with basal cell nevus syndrome who are resistant to hedgehog inhibitors, leveraging the immune system to address new occurrences of basal cell carcinoma 💡🧠🔬.
🔗 Read the full study here:
jamanetwork.com/journals/jam...
🔗 Read the full study here:
jamanetwork.com/journals/jam...
Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin Syndrome
This case series examines treatment with anti–programmed cell death 1 (PD1) immunotherapy for patients with basal cell nevus syndrome.
jamanetwork.com
December 24, 2024 at 10:52 AM
⚠️ Anti-PD1 therapy could serve as an effective systemic treatment for patients with basal cell nevus syndrome who are resistant to hedgehog inhibitors, leveraging the immune system to address new occurrences of basal cell carcinoma 💡🧠🔬.
🔗 Read the full study here:
jamanetwork.com/journals/jam...
🔗 Read the full study here:
jamanetwork.com/journals/jam...
🌟 Our latest article gives an update about prognostic biomarkers in evolving melanoma immunotherapy: From PD-L1 to gut microbiota and beyond 🧬💊
Enjoy the weekend read 📖 : link.springer.com/article/10.1...
📌 #Melanoma #Immunotherapy #ScienceForAll #ResearchMatters #Innovation #dermatology
---
Enjoy the weekend read 📖 : link.springer.com/article/10.1...
📌 #Melanoma #Immunotherapy #ScienceForAll #ResearchMatters #Innovation #dermatology
---
link.springer.com
December 21, 2024 at 11:21 AM
🌟 Our latest article gives an update about prognostic biomarkers in evolving melanoma immunotherapy: From PD-L1 to gut microbiota and beyond 🧬💊
Enjoy the weekend read 📖 : link.springer.com/article/10.1...
📌 #Melanoma #Immunotherapy #ScienceForAll #ResearchMatters #Innovation #dermatology
---
Enjoy the weekend read 📖 : link.springer.com/article/10.1...
📌 #Melanoma #Immunotherapy #ScienceForAll #ResearchMatters #Innovation #dermatology
---
What an amazing Secret Santa exchange on the lab floor! 🤩🎁🎄 So much laughter, surprises, and holiday cheer – can't wait to do it again next year! ✨🎅 @nct-heidelberg.bsky.social
December 20, 2024 at 5:21 PM
What an amazing Secret Santa exchange on the lab floor! 🤩🎁🎄 So much laughter, surprises, and holiday cheer – can't wait to do it again next year! ✨🎅 @nct-heidelberg.bsky.social
Dermatology: A group for researchers, clinicians, patient advocates, journals, and institutions passionate about dermatology research and advancing skin health! 🩺✨
#Dermatology #SkinHealth #ScienceCommunity
Leave a comment, if you want to join the starter pack 😊
go.bsky.app/7BoDoFw
#Dermatology #SkinHealth #ScienceCommunity
Leave a comment, if you want to join the starter pack 😊
go.bsky.app/7BoDoFw
December 14, 2024 at 9:15 PM
Dermatology: A group for researchers, clinicians, patient advocates, journals, and institutions passionate about dermatology research and advancing skin health! 🩺✨
#Dermatology #SkinHealth #ScienceCommunity
Leave a comment, if you want to join the starter pack 😊
go.bsky.app/7BoDoFw
#Dermatology #SkinHealth #ScienceCommunity
Leave a comment, if you want to join the starter pack 😊
go.bsky.app/7BoDoFw
Favorite protein:
Dickkopf-related protein 1
Dickkopf is German for bullhead or bullethead 😂
Dickkopf-related protein 1
Dickkopf is German for bullhead or bullethead 😂
December 9, 2024 at 9:31 AM
Favorite protein:
Dickkopf-related protein 1
Dickkopf is German for bullhead or bullethead 😂
Dickkopf-related protein 1
Dickkopf is German for bullhead or bullethead 😂
Everything #spatialomics - A hub for researchers, clinicians, companies, journals, and institutions exploring spatial omics technologies.
Leave a comment, if you’d like to join 🧬🙂
#SpatialOmics #Visium #Xenium #MERSCOPE #MultiplexIF #MIBI #OmicsResearch #Biotech #Innovation
go.bsky.app/zcDshW
December 8, 2024 at 7:55 PM
Everything #spatialomics - A hub for researchers, clinicians, companies, journals, and institutions exploring spatial omics technologies.
Leave a comment, if you’d like to join 🧬🙂
#SpatialOmics #Visium #Xenium #MERSCOPE #MultiplexIF #MIBI #OmicsResearch #Biotech #Innovation
go.bsky.app/zcDshW
Skin Cancer Research: Melanoma and beyond. A space for patient advocates, scientists, physicians, institutions, and journals dedicated to advancing skin cancer research. 🧫🧑🔬🔬
Leave a comment and let me know if you'd like to join!
#Cure #SkinCancer #Research
go.bsky.app/2wqZKrA
Leave a comment and let me know if you'd like to join!
#Cure #SkinCancer #Research
go.bsky.app/2wqZKrA
December 8, 2024 at 2:28 PM
Skin Cancer Research: Melanoma and beyond. A space for patient advocates, scientists, physicians, institutions, and journals dedicated to advancing skin cancer research. 🧫🧑🔬🔬
Leave a comment and let me know if you'd like to join!
#Cure #SkinCancer #Research
go.bsky.app/2wqZKrA
Leave a comment and let me know if you'd like to join!
#Cure #SkinCancer #Research
go.bsky.app/2wqZKrA